The Effect of Depression on Serum VEGF Level in Alzheimer’s Disease

Abstract EN

Objective.

Growing evidence suggests that angiogenesis might represent a new pathogenic mechanism involved in the progression of Alzheimer’s disease (AD).

Among angiogenic cytokines, vascular endothelial growth factor (VEGF) levels in AD patients have been evaluated, but the results are controversial among studies.

We investigated serum levels of VEGF in AD patients with depression, AD patients without depression, and the controls, respectively.

The aim of this study is to elucidate the relationship between VEGF, depression, and cognitive impairment in AD.

Methods.

The CDR (Clinical Dementia Rating), MMSE-KC (the Mini-Mental Status Examination-Korean version), and SGDS-K (the Korean version of the Geriatric Depression Scale-Short Form) were measured in the subjects.

Serum VEGF levels were measured in 24 AD patients with depression, 25 AD patients without depression, and 26 controls, using an enzyme-linked immunosorbent assay kit.

Results.

Serum VEGF levels in AD patients with depression were significantly higher than AD patients without depression or the control.

A correlation was observed between VEGF and scores on SGDS-K, but no correlation was detected between VEGF and MMSE-KC scores.

Conclusion.

Serum VEGF levels in AD patients with depression were higher than those without depression.

Depression might be associated with changes in serum levels of VEGF in AD patients.